A prospective, open-label, single-centre/multi-site, randomized clinical trial of a novel maternal microbiological “screen & treat” program compared with normal care for the prevention of preterm birth

一项新型母体微生物筛查的前瞻性、开放标签、单中心/多中心、随机临床试验

• 批准号: nhmrc : GNT1144040
• 负责人: Dr Matthew Payne
• 金额: $ 170.86万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/prospective-open-label-preterm-birth/1348578
• 关键词: prospective; open; label; single; centre

In 2014, our team launched the world-unique Western Australian Preterm Birth (PTB) Prevention Initiative and reduced the rate of PTB state-wide by 8%. Our next step is to trial a “screen & treat” program to detect women in mid-pregnancy at high risk of infection-driven PTB and treat them with antimicrobial medications. The study will involve more than 6000 women and aims to lower the rate of spontaneous PTB rate by 30%, which if applied nationally, may prevent 4500 PTBs each year.

2014年，我们的团队推出了世界上独一无二的西澳大利亚州早产（PTB）预防计划，并将全州的PTB率降低了8%。我们的下一步是试验一个“筛查和治疗”计划，以检测处于感染驱动的PTB高风险的妊娠中期妇女，并用抗菌药物治疗她们。该研究将涉及6000多名妇女，旨在将自发性PTB率降低30%，如果在全国范围内应用，每年可预防4500例PTB。